Oxaliplatin

Details About Generic Salt ::  Oxaliplatin  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS OXALIPLATIN ALKYLATOR | ANTI-NEOPLASTIC PK: D: 440 L (Vd) M: Nonenzymatic...

Paclitaxel

Details About Generic Salt ::  Paclitaxel  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS PACLITAXEL ANTI-NEOPLASTIC PK: D: Extensive M: Hepatic E: Feces (~70%, 5%...

Chlorambucil

Details About Generic Salt ::  Chlorambucil  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS CHLORAMBUCIL ALKYLATING AGENT, NITROGEN MUSTARD | ANTI-NEOPLASTIC,...

Carboplatin

Details About Generic Salt ::  Carboplatin  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS CARBOPLATIN ALKYLATING AGENT | ANTI-NEOPLASTIC PK: D: 16 L (Vd) M:...

Cisplatin

Details About Generic Salt ::  Cisplatin  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS CISPLATIN ALKYLATING AGENT, PLATINUM COORDINATION COMPLEX | ANTI-NEOPLASTIC...

Epirubicin

Details About Generic Salt ::  Epirubicin  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS EPIRUBICIN ANTHRACYCLINE | ANTI-NEOPLASTIC ANTIBIOTIC PK: D: 21-27 L/kg...

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.

I accept I decline